Phibro Animal Health (PAHC) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY26 Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q2 EPS of $0.87, $0.19 better than the analyst estimate of $0.68. Revenue for the quarter came in at $373.9 million versus the consensus estimate of $355.24 million.

GUIDANCE:

Phibro Animal Health sees FY2026 EPS of $2.93-$3.10, versus the consensus of $3.02. Phibro Animal Health sees FY2026 revenue of $1.45-1.5 billion, versus the consensus of $1.51 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• MicroVision applies to transfer listing to NASDAQ capital market
• Laser Photonics regains NASDAQ compliance after filing quarterly report